Patent · US Active

Compositions and methods for enhancing coagulation Factor VIII function

US8816054B2 · kind B2 · utility

1Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2012
Grant dateAug 26, 2014
Priority date—
Expiry dateApr 2, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Factor VIII variants and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.